Israeli Company's Bioprinted Cornea Restores Sight to Blind Patient
Translated & summarized from i24NEWS Arabic by baba
Israeli company Precise Bio has successfully implanted bioprinted corneas made from human cells into five patients at Haifa's Rambam Hospital, with the first patient regaining sight. This innovation aims to address the global shortage of donor corneas by producing multiple implants from a single donor. While promising for regenerative medicine, further clinical trials are needed to confirm safety and efficacy before wider use.
The story in 5 lines · by baba
- Precise Bio implanted bioprinted corneas from human cells into five patients at Rambam Hospital.
- The first patient regained vision in an eye previously rendered blind by disease.
- The technology aims to overcome the global shortage of donor corneas.
- Founder Aryeh Bat stated one donor can yield hundreds of implants.
- Future research may extend bioprinting to other tissues and organs.
Israeli company Precise Bio has achieved a significant medical breakthrough in tissue transplantation by successfully implanting lab-grown corneas made from human cells using bioprinting technology. The procedure was performed on five patients at Rambam Hospital in Haifa. The first patient, who had been blind in one eye, regained vision after the surgery, marking a potential major step towards new solutions for corneal disease patients. This technology utilizes donor cells to produce functional corneal tissue, aiming to alleviate the global shortage of donor corneas. Precise Bio's founder, Aryeh Bat, stated that the technique can generate hundreds of implants from a single donor, a vast improvement over the current single-implant model. The scarcity of donor corneas presents a challenge for treating many patients worldwide, as tissue availability relies solely on human donation. Bioprinting technologies hold promise for increasing tissue production, contingent on clinical trials confirming their safety and efficacy. Future aspirations for this field extend beyond corneas, with researchers hoping to develop other human tissues and potentially even organ components like hearts, livers, and kidneys, though these applications require extensive further research and testing. The implantation of bioprinted corneal tissue in five patients represents a promising advancement in regenerative medicine, with ongoing medical follow-up and future trials determining the technology's broader applicability.
